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TURGEON, S. M. AND R. L ALBIN. GABA B binding sites in early adult and aging rat brain. NEUROBIOL AGING 15(6) 
705-711, 1994.~The effect of aging on GABA n binding was investigated in rat brain. Receptor autoradiography was used to 
investigate both GABA B and GABA A binding at 2 months, 3 months, 13 months, and 23 months. GABA B binding decreases 
significantly between 2 months and 23 months of age, as does GABA A binding, with was investigated in rat brain. Receptor 
autoradiography was used to investigate both GABA B and GABA A binding at 2 months, 3 months, 13 months, and 23 months. 
GABA B binding decreases significantly between 2 months and 23 months of age, as does GABA A binding, with the greatest decrease 
between 2 and 3 months. The decrease in GABA B binding appears to be due to a decrease in binding site affinity rather than a decrease 
in receptor density. The noncompetitive GABA n antagonist zinc, the competitive GABA a antagonist CGP 35348, and the guanyl 
nucleotide analogue GTP-~/-S all inhibit GABA n binding identically in 2 month and 23 month brain. These data indicate subtle 
age-related changes in the GABA B binding in early adult life but little change with senescence. 
GABA B GABA A Aging Zinc GTP-~ CGP 35348 
~/-AMINOBUTYRIC acid (GABA) is the predominant inhibitory 
neurotransmitter in the central nervous system. A number of 
GABAergic parameters have been reported to undergo changes 
during aging. Cerebrospinal fluid GABA levels decrease with age 
in humans (19,37) and rat brain GABA levels have been reported 
either to remain stable (10) or decrease with age (2). Contradictory 
studies have reported both increased (36) and decreased (43) high- 
affinity GABA uptake in aged rat brain. Both GABA release (1) 
and glutamic acid decarboxylase (GAD) activity (34) appear to 
decrease with age. 
The GABA B receptor is one of two known central nervous 
system receptors for GABA. The other receptor, the GABA A re- 
ceptor, is a ligand gated ion channel. GABA B receptors are G-pro- 
tein linked (15,22) and activated by the GABA B selective agonist 
baclofen (4,5). Receptor activation can lead to either inhibition of 
Ca 2 ÷ currents ( 15,16,25 ) or activation of K ÷ currents (17,32) and 
can act through second messenger systems to modulate cyclic 
AMP formation (21,42,44). 
Most investigations of age-related changes in GABA receptors 
have focused on the GABA A receptor. Several studies report the 
absence of age-related changes in GABA A receptor binding (26, 
27,30,41). However, one study found selective decreases in bind- 
ing in the substantia nigra and hypothalamus with age (18). In 
addition, decreased 35S-TBPS binding to the GABA A receptor 
associated picrotoxin binding site was observed in aged animals 
(11). Whereas age-related increases in [3H]diazepam binding to 
benzodiazepine binding sites and increased enhancement of 
GABA A binding by benzodiazepines have been reported (9), the 
sensitivity of benzodiazepine binding to modulation by GABA A 
receptor binding does not appear to be altered in aged animals 
(24). Finally, functional studies have shown increased GABA in- 
hibition of firing in hippocampal pyramidal cells (26) and de- 
creased GABA A receptor-stimulated C1- uptake in membrane ves- 
icles (11) in aged rat brain. 
In contrast, the literature on age-related changes of the GABA B 
receptor is quite sparse. We have previously reported that GABA B 
binding site distribution undergoes several regional changes during 
early postnatal development which can be correlated with changes 
synaptogenic and organizational events (39). However, the only 
study investigating GABA B receptors in aging has reported that 
postsynaptic GABA B responses in hippocampal pyramidal cells 
decrease in aged rats (33). In light of evidence that GABA B re- 
ceptors are implicated in memory processes (7) and that GABA B 
receptor binding is altered in Alzheimer's disease (AD) (12,13), 
we believe that further investigation of changes in GABA B recep- 
tor binding in aging is necessary. We have used [3H]GABA re- 
ceptor autoradiography to describe the regional changes in 
GABA B binding and GABA B binding site pharmacology in rat 
brain across a wide spectrum of ages. Regional binding results are 
compared with parallel studies of GABA A binding. 
EXPERIMENTAL PROCEDURES 
Materials 
[3H]GABA (91.7 Ci/mmol) was obtained from Amersham (Ar- 
lington Heights, IL). Isoguvacine was purchased from Cambridge 
Research Chemicals (Cambridge, England). (---)Baclofen was a 
gift from Dr. R. Lovell (Ciba-Geigy, Summit, NJ). CGP 35348 
was donated by Drs. H. Schroter and L. Maitre (Ciba-Geigy, 
Basel, Switzerland). GTP-~-S was purchased from Sigma (St. 
Louis, MO). 
Requests for reprints should be addressed to Roger Albin, Neuroscience Laboratory Building, 1103 E. Huron, Ann Arbor, MI 48104-1687. 
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Animals 
Male Fisher 344/BNNia rats were obtained from Charles River 
(New York, NY) through the National Institute of Aging. For 
distribution studies, brains were used from animals aged 2 months 
(n = 6), 3 months (n = 4), 13 months (n = 6), and 23 months 
(n = 6). For the saturation and competition assays, brains were 
used from 2 month (n = 6; saturation, n = 3; competition) and 23 
month old animals (n = 6; saturation, n = 3; competition). 
Tissue Preparation 
For autoradiography experiments, animals were decapitated 
and their brains were rapidly dissected and frozen in Lipshaw 
embedding matrix surrounded by powdered dry ice. Brains were 
mounted on cryotome chucks with Lipshaw embedding matrix. 
Serial sections (20 p.m, in the horizontal plane) were cut on a 
Lipshaw cryostat at - 20°C and thaw mounted onto gelatin-coated 
slides. Sections were stored for no longer than 24 h at - 20°C prior 
to assays. 
[3H]GABA Quantitative Autoradiography 
GABA B binding sites were examined with 20 nM [3H]GABA 
in the presence of 10 I~M isoguvacine while GABA A binding sites 
were examined with 20 nM [3H]GABA in the presence of 100 IxM 
baclofen (14). Sections were run in duplicate. Sections were pre- 
washed for 30 min in buffer containing 50 mM Tris-HCl and 2.5 
mM CaC12 (pH 7.4 at + 4°C) to remove endogenous ligand and 
were then dried under a stream of cool air. Assa)~ conditions in- 
volved a 45-min incubation at + 4°C with 20 nM [~H]GABA in 50 
mM Tris-HC1 and 2.5 mM CaC12 (pH 7.4 at +4°C). In the phar- 
macology experiments, concentrations of 30 nM to 1 mM CGP 
35348, 10 nM to 100 I~M GTP-~/-S, and 1 nM to 3 mM zinc were 
included in the incubation mixture. Saturation experiments were 
FIG. 1. Autoradiographs of [3H]GABA binding to GABA B binding sites in 2- (A), 3- (B), 13- (C), 
and 23-month-old brain (D). Representative sections for each age group were chosen from animals 
whose individual GABA B binding levels most closely approximated the overall average binding 
levels for that age group. 
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performed by the method of isotopic dilution with total GABA 
concentrations from 666 pM to 33.3 p~M. For concentration points 
at and below 33.3 nM, only [3H]GABA was used. For concen- 
tration points above 33.3 nM, 33.3 nM [3H]GABA was diluted 
with nonradioactive GABA. Nonspecific binding was determined 
by the addition of 100 p,M (+)baclofen. Following incubation, 
slides were removed individually and rinsed quickly 3 times with 
3 ml buffer squirted from a repipetter and once with 3 ml 2.5% 
glutaraldehyde in acetone and immediately blown dry with warm 
air. Slides were mounted in an X-ray cassette and apposed to 
tritium sensitive film (3H-Hyperfilm, Amersham) along with stan- 
dards containing known amounts of radioactivity (ARC, Inc., St. 
Louis, MO) for 3--4 weeks at + 4°C. Films were developed for 4 
min in Kodak D19, fixed and dried. 
Data Analysis 
Ligand binding was quantified with computer-assisted densi- 
tometry using an MCID system (Imaging Research Inc., St. 
Catherine's, Ontario). To quantify ligand binding levels, the op- 
tical density of co-exposed standards was determined and a stan- 
dard curve was generated by fitting standard optical density values 
to standard radioactivity values with a fourth-degree polynomial 
regression equation as described previously (31). Standards were 
commercial 14C plastic standards (ARC Inc., St. Louis, MO), 
calibrated against previously described 3H-brain paste standards 
constructed to give a known amount of radioactivity per mg pro- 
tein (31). Optical density readings were taken in regions of interest 
and converted to fmoles/mg protein values using the standard 
curve derived from the optical density values of the standards (31). 
One-way ANOVAs were performed to assess age-related vari- 
ance in regional GABAa and GABAA binding levels and posthoc 
comparisons between individual groups were made with Scheffe6 
F tests. IC5o values were calculated in 4 regions for zinc and CGP 
35348 and in the cerebellar molecular layer for GTP-~/-S with a 
dose-response semi-log plot. Unpaired student t tests were used to 
compare IC5o values in young and aged rats. Hill numbers for 
CGP 35348 were determined by generating Hill plots as described 
by Bylund (8) and analyzed for statistical significance with a one 
group t test. CGP 35348 inhibition curves and saturation data were 
analyzed using the computer program LIGAND (Biosoft, Furgu- 
son, MO). LIGAND performed a statistical analysis of the residual 
variance of one- versus two-site curve fits for the combined data 
from 6 animals from each age group at each saturation point using 
a partial F test. A two-site fit was considered to be preferable when 
the residual variance for a two-site fit was significantly lower than 
the residual variance for a one-site fit at significance levels ofp < 
0.05. 
RESULTS 
Regional Distribution of GABA s and GABAA Binding in Aging 
GABAa binding decreased significantly from two months to 23 
months in all regions examined while significant decreases in 
GABA A binding were seen in cerebellar granule cell layer, thal- 
amus, striatum, and the CA 1 and CA3 regions of the hippocampus 
(Fig. 1 and Fig. 2) and in the cerebellar granule cell layer (GCL; 
data not shown). Due to the high level of binding in the GCL, the 
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FIG. 2. [3H]GABA binding to GABA a and GABA A binding sites in 2- (n = 6), 3- (n = 4), 13- (n = 6), 
and 23-month-old (n = 6) rats. Analysis of variance (ANOVA) revealed significant changes in GABA a 
binding across age groups in all regions (p < 0.05, one-factor ANOVA) and significant changes in GABAA 
binding across age groups in the thalamus, striatum, dentate, CA1, CA3, and septum (p < 0.05, one-factor 
ANOVA). Posthoc tests revealed significant decreases in GABA B binding between the 2-month-old group and 
some older groups in all regions and significant decreases in GABAA binding between the 2-month-old group 
and some older groups in the thalamus, striatum, CA1, and CA3. Error bars represent SEM values. *(p < 
0.05, as compared to the 2-month-old group, Scheffe6 F test). 
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FIG. 3. Scatchard analysis of [3H]GABA binding to GABA a binding sites 
in the cerebellar molecular layer (A), thalamus (B), and cortex (C) of 2- 
(O) and 23-month-old (O) rats. The plot is nonlinear, indicating the pres- 
ence of more than one binding site. A two-site fit for [3H]GABA binding 
to GABAa binding sites was preferred in all regions at both ages as de- 
termined by a nonlinear regression of the saturation data and a partial F test 
using the LIGAND program (p < 0.005). Each point represents average 
binding levels from six animals. Error bars represent SEM values. 
vidual age groups revealed that the only significant changes in 
binding were those observed between the 2-month group and the 
older groups. In the GCL, GABA n binding in all older age groups 
was significantly less than in the 2-month group. No significant 
decreases in binding were observed between individual age groups 
after 3 months of age. 
Saturation Analysis 
Analysis of the saturation data using the computer program 
LIGAND suggests that [3H]GABA binds to two GABA B binding 
sites in the cerebellar molecular layer, thalamus, and neocortex in 
both 2-month and 23-month animals. A two-site fit was preferred 
in all of these regions with significance levels of p = 0.002 or 
lower. Scatchard curves generated from saturation data in both 2- 
and 23-month-old animals also illustrate a two-site fit for 
[3H]GABA binding to GABAB binding sites in the cerebellar 
molecular layer (Fig. 3). Both KD and Bma x values for the high and 
low affinity sites increased in aged animals in all regions except 
the thalamus were the Bma X was not increased for the high affinity 
site (Table 1). 
Competition Assays 
GABA B binding was displaced equipotently in young and aged 
brains by the noncompetitive GABA a antagonist zinc and the 
competitive GABA a antagonist CGP 35348 (Fig. 4 A and B). The 
IC5o values for these compounds are reported in Table 2. 
Whereas inhibiting GABA B binding at higher doses, zinc also 
enhanced GABAB binding at lower doses. In the cerebellar mo- 
lecular layer, GABA B binding was enhanced to 136.0 % - 10.7% 
by 30 mM zinc and to 127.9% --- 8.5% (p < 0.05, one-tailed t test) 
by 100 mM zinc in 2-month-old brains, and to 133.1% -+ 17.8% 
by 30 mM zinc and to 118.5% - 7.7% by 1130 mM zinc in 
23-month-old brains. Similar levels of enhancement were ob- 
served in the dentate and neocortex but not in the thalamus. 
Hill plots and equilibrium binding analysis were generated for 
the inhibition of GABA a binding by CGP 35348 in the cerebellar 
molecular layer. The Hill coefficient for the young animals was 
significantly different than 1 (nil = 1.313 --- 0.016, p < 0.05, 
two-tailed t test) while in adult animals a nonsignificant trend 
away from 1 was observed (nil = 1.502 ----- 0. 190). Equilibrium 
binding analysis using the LIGAND computer program revealed 
that, in young animals, CGP 35348 displaces binding from both a 
high affinity site (K I = 5.0 IxM, B~a x = 22.8 fM) and a low 
affinity site (K~ = 78.5 IxM, Bma x = 3.2 fM). However, in aged 
animals a single site fit was preferred (K~ = 17.8 p~M, B,~× = 6.6 
fM). 
TABLE 1 
K D AND Bmax VALUES FOR GABAB BINDING IN YOUNG ADULT 
AND AGED RATS 
ML Cortex Thalamus 
Young (2 months) 
K o high (nM) 23.9 
B ,~  (fM/mg protein) 20.9 
Ko low (nM) 700 
B,,,,= (fM/mg protein) 80.4 
Aged (23 months) 
K o high (nM) 70.7 
B,,,~ (fM/mg protein) 36.0 
Ko low (riM) 4800 
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FIG. 4. Inhibition of [3H]GABA binding to the GABA B binding site in the 
cerebellar molecular layer of 2- (O) and 23-month-old (0) old rats by the 
competitive GABA B antagonist CGP 35348 (A), the noncompetitive 
GABAB antagonist zinc (B), and the guanyl nucleotide analogue GTP-~-S 
(C). Each point represents average binding levels from three animals. Error 
bars represent SEM values. No significant change in IC~ values from 2- 
to 2-months was observed for any of these compounds. CGP 35348 was 
found to inhibit [3H]GABA binding to two GABA B binding sites with 
different affinities for the antagonist (see Results section). 
In addition, the guanyl nucleotide analogue GTP-~/-S displaced 
GABAB binding equipotently in both young and aged animals 
(Fig. 4C) with ICsos in the cerebellar molecular layer of 763.4 + 
108.1 nM and 619.1 + 237.1 nM, respectively. 
DISCUSSION 
Regional Distribution of GABA B Binding in Aging 
Our results indicate an age-related decrease in GABA B binding 
in all regions examined without qualitative changes in the regional 
distribution of binding. GABA B binding also exhibited a down- 
ward trend in most regions with aging, however, significant de- 
creases in binding were found only between the 2-month-old group 
and the older groups. Taken in combination with our previous data 
(39), these results indicate continuous decreases in GABA B bind- 
ing from the time where GABAB binding peaks during the first 
2-3 postnatal weeks of life until the third postnatal month, from 
which point GABAn binding remains fairly stable throughout 
adult life. 
The drop in GABA B binding between 2 and 3 months may 
coincide with other changes observed around puberty. GABA a 
binding has been reported to be more sensitive to pertussis toxin at 
10-12 weeks of age than at earlier ages, indicating changes in 
receptor-G-protein linkage (23). Whereas the authors of this report 
did not comment on changes in overall binding levels, their figures 
also indicate decreases in GABA a binding between 7- to 8-week- 
old animals and 10- to 12-week-old animals in some regions (23). 
GABA A binding was also found to decrease in some regions. 
Our results are not necessarily in disagreement with previous stud- 
ies showing the absence of significant changes in GABA A binding 
with age as most of these studies used 3-month-old or older rats as 
their young age group. Whereas we did find a downward trend in 
GABA A binding with age, the only significant age-related de- 
creases were found in comparison to the 2-month-old group. 
Saturation Analysis 
Saturation studies were performed to assess the nature of the 
decrease in GABA a binding observed between 2 months and 23 
months of age. [3H]GABA appears to be binding to both a high 
and a low affinity GABA B binding site at both ages in the cere- 
bellar molecular layer, neocortex, and thalamus, as a two-site fit 
was preferred by the computer program LIGAND for GABA B 
binding in these regions. This finding is in agreement with our 
previous observation of a two-site fit for GABA B binding in early 
postnatal and young adult Sprague-Dawley rat brain (39). 
The decrease in binding seen between 2 months and 23 months 
appears to be due to changes in the affinity of the receptors rather 
than a decrease in receptor number. Both K o and B ~ x  values for 
high and low affinity binding sites increased between 2 months 
and 23 months. The observation of decreased affinity and in- 
creased receptor number in the presence of decreased binding sug- 
gests that the reduction in binding is due to a decrease in the 
affinity of the binding site for the ligand, rather than a decrease in 
receptor number. Furthermore, an analysis of the predicted change 
in binding using the K o and Bm~ , values in the equation B = 
((B~,~I[F])/(Kol + [F])) + ((B~x2[F])/(Ko2 + [F]))predicts a 
43% decrease in GABA B binding in the cerebellar molecular layer 
whereas the actual decrease in binding observed is 42%, support- 
ing the accuracy of the observed changes. Changes in GABA B 
binding site affinity between 2 months and 23 months are not 
surprising in light of the changes in GABA s receptor G-protein 
linkage reported following puberty (23). 
The observed increase in binding site affinity in aged animals 
suggests that a different type of GABA B receptor is present in 
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TABLE 2 
REGIONAL IC3o VALUES FOR INHIBITION OF GABAa BINDING BY ZINC AND CGP 35348 
ML Cortex Thalarnus Dentate 
Zinc (mM) 
2 mos. 1.14 -4- 0.94 1.073 ± 0.24 0.75 - 0.23 1.37 ± 0.39 
23 rnos. 0.94 ± 0.03 1.206 -+ 0.22 0.80 ~ 0.08 1.t9 ± 0.21 
CGP 35348 (ixM) 
2 mos. 18.04 ± 2.04 47.13 + 9.35 58.75 + 16.87 22,77 + 9.80 
23 mos. 19.63 ± 3.09 31.12 + 13.01 33.35 + 8.82 15.06 + 4.51 
Values are mean --- SEM. 
these animals than in the young adults. This difference may result 
from a change in the G-protein coupling ability of the receptor. 
However, a change in the proportion of receptor subtypes with 
different affinities for GABA could produce the same result. In 
either case, the presence of GABA B receptor heterogeneity is sug- 
gested by these data. 
Competition Assays 
The noncompetitive GABA B antagonist zinc, the competitive 
antagonist CGP 35348, and the guanyl nucleotide analogue GTP- 
~/-S all displace GABA B binding identically in 2-month-old brain 
and 23-month-old brain. 
Age-related changes in the effect of zinc on GABAB binding 
have been observed during development. Zinc displaces GABAB 
binding more potently during early postnatal development as com- 
pared to adulthood (39). In addition, zinc enhances GABAB bind- 
ing in certain regions at lower doses in adult brain (40) but not 
early postnatal brain (39). Whereas the enhancement of GABAB 
binding by low concentrations of zinc is only significant in the 
molecular layer of 2-month-old animals, the absence of significant 
changes elsewhere is probably due to the relatively large SE and 
small n. Because the binding curves for 2- and 23-month-old 
brains appear virtually superimposable and significant enhance- 
ment has been observed previously (40), we suggest that zinc is 
enhancing GABAB binding similarly in both age groups. 
The competitive GABAB antagonist CGP 35348 also displaced 
GABAB binding identically in 2- and 23-month-old rat brain, 
Computer analysis of this inhibition using LIGAND demonstrated 
that CGP 35348 is displacing GABA u binding from both a high 
and a low affinity binding site in the cerebellar molecular layer of 
2-month-old brain but from only one site in the 23-month-old 
brain. Decreased overall levels of GABA B binding in the older 
animals lead to increased variability which may be preventing the 
curve fitting program from obtaining a preferable two-site fit in 
these brains. Displacement curves for CGP 35348 appear to be 
superimposable, suggesting that inhibition of GABA B binding by 
CGP 35348 is the same in both young and aged animals. 
The observation of Hill numbers significantly greater than one 
for the displacement of GABA B binding by CGP 35348 in the 
cerebellar molecular layer of 2-month-old brains also suggests a 
complex interaction of this compound with GABA B binding sites. 
Because antagonists cannot discriminate between high and low 
affinity receptor states, the observation of a two-site fit for CGP 
35348 inhibition suggests that there are two different populations 
of GABAB receptors with different affinities for CGP 35348. Our 
results present further evidence for multiple subtypes of GABA B 
receptors in rat brain (3,6,35). 
Finally, the guanyI nucleotide analogue GTP-~/-S inhibits 
GABAB binding in 2- and 23-month-old animals. This finding 
suggests that GABA B binding sites in both young adult and aged 
brain are functionally coupled to G-proteins, confirming previous 
results in young adults (38) and illustrating the absence of a change 
in the presence of functional coupling with aging, We do not see 
any significant changes in the ability for GTP--y-S to inhibit bind- 
ing between age groups, a finding that is in agreement with pre- 
viously reported data (23). However, there may be age-related 
changes in the types of G-proteins to which GABAn binding sites 
are coupled (23). 
In conclusion, we find that GABA B binding decreases signif- 
icantly from 2 to 23 months in rat brain Binding decreases most 
dramatically between 2 and 3 months and then levels off, changing 
very little in the next 2 years. Saturation studies reveal a two-site 
fit for GABAB binding in both young and aged animals and the 
age-related decrease in GABA B binding appears to be due to an 
decrease in binding site affinities rather than a decrease in receptor 
density. This decrease in affinity may result from either a change 
in receptor-G-protein coupling or a change in the proportion of 
receptor subtypes with different affinities for GABA. Finally, the 
pharmacological profiles of GABAa receptor binding appear to be 
similar in young and aged animals, suggesting that the functional 
properties of GABA B binding are stable throughout adult life. 
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